Variant report
Variant | nsv522581 |
---|---|
Chromosome Location | chr11:24637870-24657338 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:24633675..24635960-chr11:24640173..24641928,2 | MCF-7 | breast: | |
2 | chr11:24637190..24639298-chr11:24640996..24643885,2 | K562 | blood: | |
3 | chr11:24580149..24580792-chr11:24639250..24640044,2 | MCF-7 | breast: | |
4 | chr11:24637190..24639298-chr11:24640996..24643885,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7119179 | chr11:24637870-24637871 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs577662600 | chr11:24637908-24637909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73433068 | chr11:24637914-24637915 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs556282330 | chr11:24637937-24637938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576297653 | chr11:24637945-24637946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12293420 | chr11:24637972-24637973 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs34321439 | chr11:24637985-24637986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79962133 | chr11:24637992-24637993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148276843 | chr11:24637993-24637994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77740271 | chr11:24638014-24638015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs71041787 | chr11:24638015-24638016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs71894225 | chr11:24638018-24638019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201675157 | chr11:24638019-24638020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375973227 | chr11:24638020-24638021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374260342 | chr11:24638021-24638022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs202140144 | chr11:24638022-24638023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs56254525 | chr11:24638024-24638025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs56175528 | chr11:24638026-24638027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs61413263 | chr11:24638048-24638049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373585613 | chr11:24638088-24638089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376921879 | chr11:24638119-24638120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532998741 | chr11:24638134-24638135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546091446 | chr11:24638163-24638164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71456130 | chr11:24638188-24638189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12287940 | chr11:24638189-24638190 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs569414852 | chr11:24641606-24641607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560292713 | chr11:24641612-24641613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538338454 | chr11:24641616-24641617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116073450 | chr11:24641654-24641655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574671017 | chr11:24641660-24641661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192797115 | chr11:24641664-24641665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185501844 | chr11:24641667-24641668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189172588 | chr11:24641699-24641700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs11028072 | chr11:24641726-24641727 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs11028073 | chr11:24641758-24641759 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs140903704 | chr11:24641806-24641807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs386751683 | chr11:24641809-24641810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs114322593 | chr11:24641810-24641811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558679181 | chr11:24641813-24641814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376744369 | chr11:24641861-24641862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12418943 | chr11:24641934-24641935 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs530250629 | chr11:24641944-24641945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566177486 | chr11:24641975-24641976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192602165 | chr11:24641981-24641982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs139954484 | chr11:24641982-24641983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567059035 | chr11:24642010-24642011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537781379 | chr11:24642035-24642036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12099381 | chr11:24642040-24642041 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs569252337 | chr11:24642048-24642049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143469835 | chr11:24642071-24642072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:24637800-24638200 | Enhancers | Fetal Brain Male | brain |
2 | chr11:24641600-24643200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr11:24643200-24644000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr11:24644000-24644200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr11:24644000-24644400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr11:24644000-24644600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr11:24644600-24645200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr11:24646000-24646600 | Enhancers | Fetal Intestine Large | intestine |
9 | chr11:24649600-24650000 | Enhancers | Fetal Brain Male | brain |
10 | chr11:24649600-24650000 | Enhancers | Fetal Heart | heart |
11 | chr11:24656400-24658600 | Enhancers | Hela-S3 | cervix |
12 | chr11:24657200-24657400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr11:24657200-24657600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr11:24657200-24657600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
15 | chr11:24657200-24658000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr11:24657200-24658400 | Enhancers | NHEK | skin |
17 | chr11:24657200-24659600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |